CALCA and migraine disorder: These findings highlight not only the therapeutic value of CGRP-targeted agents in this difficult-to-treat population but also the importance of early recognition of migraine phenotypes to guide treatment selection and improve clinical outcomes in patients initially diagnosed with NDPH-like continuous headaches [5,6].